{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:12:55Z","timestamp":1791231175799,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100003100","name":"F\u00e9d\u00e9ration Fran\u00e7aise de Cardiologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003100","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006138","name":"Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019Hypertension Art\u00e9rielle","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006138","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s40265-023-01842-3","type":"journal-article","created":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T09:03:13Z","timestamp":1677834193000},"page":"429-437","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Aspirin for the Prevention of Early and Severe Pre-Eclampsia Recurrence: A Real-World Population-Based Study"],"prefix":"10.1007","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6838-8804","authenticated-orcid":false,"given":"Gr\u00e9gory","family":"Lailler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mence","family":"Grave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Gabet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nolwenn","family":"Regnault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Deneux-Tharaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Kretz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilis","family":"Tsatsaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Plu-Bureau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Blacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Olie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,3]]},"reference":[{"issue":"10297","key":"1842_CR1","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0140-6736(20)32335-7","volume":"398","author":"LC Chappell","year":"2021","unstructured":"Chappell LC, Cluver CA, Kingdom J, Tong S. Pre-eclampsia. Lancet. 2021;398(10297):341\u201354.","journal-title":"Lancet"},{"issue":"4","key":"1842_CR2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.bpobgyn.2011.01.006","volume":"25","author":"JA Hutcheon","year":"2011","unstructured":"Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 2011;25(4):391\u2013403.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"1","key":"1842_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","volume":"72","author":"MA Brown","year":"2018","unstructured":"Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, Hall DR, Warren CE, Adoyi G, Ishaku S. International Society for the Study of Hypertension in P Hypertensive Disorders of Pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018;72(1):24\u201343.","journal-title":"Hypertension"},{"issue":"7","key":"1842_CR4","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1111\/jch.14254","volume":"23","author":"V Olie","year":"2021","unstructured":"Olie V, Moutengou E, Grave C, Deneux-Tharaux C, Regnault N, Kretz S, Gabet A, Mounier-Vehier C, Tsatsaris V, Plu-Bureau G, Blacher J. Prevalence of hypertensive disorders during pregnancy in France (2010\u20132018): the nationwide CONCEPTION study. J Clin Hypertens (Greenwich). 2021;23(7):1344\u201353.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"8433","key":"1842_CR5","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/S0140-6736(85)92207-X","volume":"1","author":"M Beaufils","year":"1985","unstructured":"Beaufils M, Uzan S, Donsimoni R, Colau JC. Prevention of pre-eclampsia by early antiplatelet therapy. Lancet. 1985;1(8433):840\u20132.","journal-title":"Lancet"},{"issue":"9575","key":"1842_CR6","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","volume":"369","author":"LM Askie","year":"2007","unstructured":"Askie LM, Duley L, Henderson-Smart DJ, Stewart LA, Group PC. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet. 2007;369(9575):1791\u20138.","journal-title":"Lancet"},{"issue":"2 Pt 1","key":"1842_CR7","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","volume":"116","author":"E Bujold","year":"2010","unstructured":"Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, Forest JC, Giguere Y. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol. 2010;116(2 Pt 1):402\u201314.","journal-title":"Obstet Gynecol"},{"issue":"10","key":"1842_CR8","doi-asserted-by":"publisher","first-page":"695","DOI":"10.7326\/M13-2844","volume":"160","author":"JT Henderson","year":"2014","unstructured":"Henderson JT, Whitlock EP, O\u2019Connor E, Senger CA, Thompson JH, Rowland MG. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the US preventive services task force. Ann Intern Med. 2014;160(10):695\u2013703.","journal-title":"Ann Intern Med"},{"issue":"3","key":"1842_CR9","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ajog.2017.11.561","volume":"218","author":"S Roberge","year":"2018","unstructured":"Roberge S, Bujold E, Nicolaides KH. Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol. 2018;218(3):287\u201393.","journal-title":"Am J Obstet Gynecol."},{"issue":"2","key":"1842_CR10","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","volume":"216","author":"S Roberge","year":"2017","unstructured":"Roberge S, Nicolaides K, Demers S, Hyett J, Chaillet N, Bujold E. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. Am J Obstet Gynecol. 2017;216(2):110\u201320.","journal-title":"Am J Obstet Gynecol."},{"issue":"7","key":"1842_CR11","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1056\/NEJMoa1704559","volume":"377","author":"DL Rolnik","year":"2017","unstructured":"Rolnik DL, Wright D, Poon LC, O\u2019Gorman N, Syngelaki A, de Paco MC, Akolekar R, Cicero S, Janga D, Singh M, Molina FS, Persico N, Jani JC, Plasencia W, Papaioannou G, Tenenbaum-Gavish K, Meiri H, Gizurarson S, Maclagan K, Nicolaides KH. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;377(7):613\u201322.","journal-title":"N Engl J Med"},{"issue":"2","key":"1842_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ajog.2016.10.016","volume":"216","author":"S Meher","year":"2017","unstructured":"Meher S, Duley L, Hunter K, Askie L. Antiplatelet therapy before or after 16 weeks\u2019 gestation for preventing preeclampsia: an individual participant data meta-analysis. Am J Obstet Gynecol. 2017;216(2):121\u20138.","journal-title":"Am J Obstet Gynecol."},{"key":"1842_CR13","first-page":"10","volume":"2019","author":"L Duley","year":"2019","unstructured":"Duley L, Meher S, Hunter KE, Seidler AL, Askie LM. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2019;2019:10.","journal-title":"Cochrane Database Syst Rev."},{"issue":"2S","key":"1842_CR14","doi-asserted-by":"publisher","first-page":"S1222","DOI":"10.1016\/j.ajog.2020.08.018","volume":"226","author":"G Scott","year":"2022","unstructured":"Scott G, Gillon TE, Pels A, von Dadelszen P, Magee LA. Guidelines-similarities and dissimilarities: a systematic review of international clinical practice guidelines for pregnancy hypertension. Am J Obstet Gynecol. 2022;226(2S):S1222\u201336.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"1842_CR15","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1097\/AOG.0000000000002708","volume":"132","author":"ACOG Committee Opinion No","year":"2018","unstructured":"ACOG Committee Opinion No. 743: low-dose aspirin use during pregnancy. Obstet Gynecol. 2018;132(1):e44\u201352.","journal-title":"Obstet Gynecol"},{"key":"1842_CR16","unstructured":"WHO. WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. 2011."},{"key":"1842_CR17","first-page":"275","volume":"28","author":"T Pottecher","year":"2008","unstructured":"Pottecher T, Luton D, Zupan V, Collet M. Multidisciplinary management of severe pre-eclampsia (PE). Experts\u2019 guidelines 2008. Annales Fran\u00e7aises d\u2019Anesth\u00e9sie et de R\u00e9animation. 2008;28:275\u201381.","journal-title":"Annales Fran\u00e7aises d\u2019Anesth\u00e9sie et de R\u00e9animation."},{"key":"1842_CR18","doi-asserted-by":"crossref","unstructured":"Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomstrom-Lundqvist C, Cifkova R, De Bonis M, Iung B, Johnson MR, Kintscher U, Kranke P, Lang IM, Morais J, Pieper PG, Presbitero P, Price S, Rosano GMC, Seeland U, Simoncini T, Swan L, Warnes CA, Group ESCSD. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39(34):3165\u2013241.","DOI":"10.5603\/KP.2019.0049"},{"issue":"34","key":"1842_CR19","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2018.33.e213","volume":"33","author":"HS Kim","year":"2018","unstructured":"Kim HS, Lee S, Kim JH. Real-world evidence versus randomized controlled trial: clinical research based on electronic medical records. J Korean Med Sci. 2018;33(34): e213.","journal-title":"J Korean Med Sci"},{"issue":"6","key":"1842_CR20","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ajog.2017.08.110","volume":"217","author":"D Wright","year":"2017","unstructured":"Wright D, Poon LC, Rolnik DL, Syngelaki A, Delgado JL, Vojtassakova D, de Alvarado M, Kapeti E, Rehal A, Pazos A, Carbone IF, Dutemeyer V, Plasencia W, Papantoniou N, Nicolaides KH. Aspirin for evidence-based preeclampsia prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia. Am J Obstet Gynecol. 2017;217(6):685.","journal-title":"Am J Obstet Gynecol."},{"key":"1842_CR21","first-page":"2","volume":"2","author":"P Boucheron","year":"2021","unstructured":"Boucheron P, Lailler G, Moutengou E, Regnault N, Gabet A, Deneux-Tharaux C, Kretz S, Grave C, Mounier-Vehier C, Tsatsaris V, Plu-Bureau G, Blacher J, Olie V. Hypertensive disorders of pregnancy and onset of chronic hypertension in France: the nationwide CONCEPTION study. Eur Heart J. 2021;2:2.","journal-title":"Eur Heart J."},{"issue":"4","key":"1842_CR22","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.respe.2010.04.005","volume":"58","author":"P Tuppin","year":"2010","unstructured":"Tuppin P, de Roquefeuil L, Weill A, Ricordeau P, Merliere Y. French national health insurance information system and the permanent beneficiaries sample. Rev Epidemiol Sante Publique. 2010;58(4):286\u201390.","journal-title":"Rev Epidemiol Sante Publique"},{"issue":"9","key":"1842_CR23","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.jgyn.2013.09.004","volume":"43","author":"C Quantin","year":"2014","unstructured":"Quantin C, Cottenet J, Vuagnat A, Prunet C, Mouquet MC, Fresson J, Blondel B. Quality of perinatal statistics from hospital discharge data: comparison with civil registration and the 2010 National Perinatal Survey. J Gynecol Obstet Biol Reprod (Paris). 2014;43(9):680\u201390.","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"issue":"9","key":"1842_CR24","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1080\/03007995.2018.1477747","volume":"34","author":"CA Forbes","year":"2018","unstructured":"Forbes CA, Deshpande S, Sorio-Vilela F, Kutikova L, Duffy S, Gouni-Berthold I, Hagstrom E. A systematic literature review comparing methods for the measurement of patient persistence and adherence. Curr Med Res Opin. 2018;34(9):1613\u201325.","journal-title":"Curr Med Res Opin"},{"key":"1842_CR25","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1136\/bmj.i1753","volume":"353","author":"E Bartsch","year":"2016","unstructured":"Bartsch E, Medcalf KE, Park AL, Ray JG. High Risk of Pre-eclampsia Identification G. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ. 2016;353:1753.","journal-title":"BMJ"},{"issue":"1","key":"1842_CR26","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/s12884-022-04686-z","volume":"22","author":"N Tavananezhad","year":"2022","unstructured":"Tavananezhad N, Bolbanabad AM, Ghelichkhani F, Effati-Daryani F, Mirghafourvand M. The relationship between health literacy and empowerment in pregnant women: a cross-sectional study. BMC Pregnan Childbirth. 2022;22(1):351.","journal-title":"BMC Pregnan Childbirth"},{"issue":"3","key":"1842_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-042753","volume":"11","author":"K Thomson","year":"2021","unstructured":"Thomson K, Moffat M, Arisa O, Jesurasa A, Richmond C, Odeniyi A, Bambra C, Rankin J, Brown H, Bishop J, Wing S, McNaughton A, Heslehurst N. Socioeconomic inequalities and adverse pregnancy outcomes in the UK and Republic of Ireland: a systematic review and meta-analysis. BMJ Open. 2021;11(3): e042753.","journal-title":"BMJ Open"},{"issue":"1","key":"1842_CR28","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1186\/s12889-022-13590-2","volume":"22","author":"C Rossiter","year":"2022","unstructured":"Rossiter C, Henry A, Roberts L, Brown MA, Gow M, Arnott C, Salisbury J, Ruhotas A, Hehir A, Denney-Wilson E. Optimising mothers\u2019 health behaviour after hypertensive disorders of pregnancy: a qualitative study of a postnatal intervention. BMC Public Health. 2022;22(1):1259.","journal-title":"BMC Public Health"},{"key":"1842_CR29","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fcvm.2019.00160","volume":"6","author":"NA Lui","year":"2019","unstructured":"Lui NA, Jeyaram G, Henry A. Postpartum interventions to reduce long-term cardiovascular disease risk in women after hypertensive disorders of pregnancy: a systematic review. Front Cardiovasc Med. 2019;6:160.","journal-title":"Front Cardiovasc Med."},{"key":"1842_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2255","volume":"338","author":"S Hernandez-Diaz","year":"2009","unstructured":"Hernandez-Diaz S, Toh S, Cnattingius S. Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study. BMJ. 2009;338: b2255.","journal-title":"BMJ"},{"issue":"2","key":"1842_CR31","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1081\/PRG-120021060","volume":"22","author":"P von Dadelszen","year":"2003","unstructured":"von Dadelszen P, Magee LA, Roberts JM. Subclassification of preeclampsia. Hypertens Pregnan. 2003;22(2):143\u20138.","journal-title":"Hypertens Pregnan"},{"key":"1842_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jri.2019.07.004","volume":"134\u2013135","author":"AC Staff","year":"2019","unstructured":"Staff AC. The two-stage placental model of preeclampsia: An update. J Reprod Immunol. 2019;134\u2013135:1\u201310.","journal-title":"J Reprod Immunol"},{"issue":"12","key":"1842_CR33","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1016\/j.ajpath.2016.08.010","volume":"186","author":"S Panagodage","year":"2016","unstructured":"Panagodage S, Yong HE, Da Silva CF, Borg AJ, Kalionis B, Brennecke SP, Murthi P. Low-dose acetylsalicylic acid treatment modulates the production of cytokines and improves trophoblast function in an in vitro model of early-onset preeclampsia. Am J Pathol. 2016;186(12):3217\u201324.","journal-title":"Am J Pathol"},{"issue":"4","key":"1842_CR34","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.respe.2015.05.001","volume":"63","author":"A Pierron","year":"2015","unstructured":"Pierron A, Revert M, Goueslard K, Vuagnat A, Cottenet J, Benzenine E, Fresson J, Quantin C. Evaluation of the metrological quality of the medico-administrative data for perinatal indicators: A pilot study in 3 university hospitals. Rev Epidemiol Sante Publique. 2015;63(4):237\u201346.","journal-title":"Rev Epidemiol Sante Publique"}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-023-01842-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40265-023-01842-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-023-01842-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T15:31:13Z","timestamp":1680795073000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40265-023-01842-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,3]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["1842"],"URL":"https:\/\/doi.org\/10.1007\/s40265-023-01842-3","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,3]]},"assertion":[{"value":"31 January 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S.K. reports, outside the submitted work, nonfinancial support from Lilly France, Novo Nordisk, Novartis Pharma, Roche diabetes care, Lifescan, Abbott France, Sanofi, ViiV Healthcare, Servier, Becton Dickinson, and personal fees from Icomed, Pascaleo, BT3SI, M3global research. J.B. reports, outside the submitted work, personal fees from Abbott, Bayer, Bottu, Ferring, Steripharma, Kantar, Teriak, personal fees and non-financial support from Pfizer, Quantum Genomics, personal fees from Sanofi and Servier. All other authors (GL, CG, AG, NR, CDT, VT, GPB, JB, and VO) declare no conflict of interest that might be relevant to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This work was supported by the French Cardiology Federation (Thematic grant 2019: cardiovascular diseases in women), the French Hypertension Society (SFHTA) and the French Hypertension Research Foundation (FRHTA). The funders had no role in the study design, data collection, data analysis, decision to publish, or drafting of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"VO, JB, CDT, SK, VT, NR and GPB conceived and designed the analysis. GL, AG and CG collected the data and performed the analysis. GL wrote the paper under the supervision of VO and JB.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contributions"}},{"value":"In line with French national regulations and ethics committee, Institutional Review Board (IRB) approval was not required for this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Sant\u00e9 Publique France\u2014the French public health agency\u2014has full and chronic access to the SNDS (governmental deliberation no. 2016\u2013316, 13 October 2016). We cannot share National Health Data System data as they are only available on a secure portal. Authorization to access this portal needs registration and clearance.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}